|Articles|October 12, 2020
Patient Support Programs: Considerations for Crisis Management and Risk Mitigation
Author(s)Covance
This whitepaper discusses the importance of patient support programs and why a robust risk mitigation plan is critical to ensure that patients receive their therapy during crises.
Related Content
Trending on PharmExec
1
AstraZeneca Shares Drop Following Wainua’s Failed Heart Disease Trial
2
U.S. Supreme Court Weighs Inducement Liability Beyond FDA Carve-Out Labels
3
Pharma M&A Roundup: Chemomab Therapeutics Enters Merger Agreement with Scipher Medicine, Teva and Polpharma Biologics Enter Global Licensing Agreement
4
FDA Approves Subcutaneous Sarclisa Escena for Multiple Myeloma
5